Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-4,981
Closed -$5.13M 110
2015
Q4
$5.13M Buy
4,981
+692
+16% +$695K 1.28% 30
2015
Q3
$4.05M Buy
4,289
+519
+14% +$541K 1.18% 31
2015
Q2
$3.94M Buy
+3,770
New +$3.95M 1% 43

Other funds holding AGN.PRA

L & S Advisors's AGN.PRA Position: Q1 2016 in Review

L & S Advisors sold out of Allergan plc (AGN.PRA) in Q1 2016, closing a stake of 4,981 shares — an estimated $5.13M sold.

L & S Advisors first reported a position in AGN.PRA in Q2 2015 and held it in 3 quarters. The position peaked at $5.13M in Q4 2015. 103 funds tracked by Wall St. Rank hold AGN.PRA as of Q1 2016.

  • L & S Advisors reported no remaining Allergan plc position as of Q1 2016 after selling out during the quarter.
  • L & S Advisors sold 4,981 Allergan plc shares in Q1 2016, an estimated $5.13M.
  • L & S Advisors first reported a position in Allergan plc in Q2 2015 and held it in 3 quarters.
  • L & S Advisors's Allergan plc position peaked at $5.13M in Q4 2015.
  • 103 funds tracked by Wall St. Rank held Allergan plc as of Q1 2016.

Based on L & S Advisors's 13F filing for Q1 2016, filed 13 May 2016.